Howard Hughes Medical Institute Investigators Cigall Kadoch and Clifford Brangwynne teamed up to challenge long-held beliefs in the scientific community about how – or even if – structureless, unorganized regions of proteins play specific roles in causing or preventing disease pathogenesis. Their work was published earlier this month in the journal Cell.
To understand the significance of the duo’s findings, it helps to first dive deep into the ways in which cells alter genomic structure through a process known as chromatin remodeling. About two meters – or six and a half feet – of DNA are packed inside each cell’s nucleus, which measures no larger than a pinhead. To fit in that space, DNA winds around proteins, forming a compact structure called chromatin. At the Dana-Farber Cancer Institute, Kadoch and her lab have spent years studying chromatin remodeling complexes – molecular machines made up of multiple proteins that change the physical structure of chromatin and, thus, suppress or enable the activity of genes in a programmatic manner.
In recent years, her lab’s focus has centered on a family of complexes known as mammalian SWI/SNF chromatin remodeling complexes – commonly referred to as BAF complexes – which have garnered significant attention due to their disruption and involvement in human disease. BAF complexes are one of the most frequently mutated cellular entities in human cancer, second only to TP53, a well-studied tumor suppressor gene. Studies have shown that approximately 20 percent of human cancers bear BAF complex mutations and that such disruptions are also among the most common in neurodevelopmental disorders (NDDs) such as autism and intellectual disability.
.jpg)
.jpg)


.jpg)

.jpg)
.jpg)




